Head-to-head · WeighScore
Harper Meds vs NowPatient
The verdict
Harper Meds takes it — 72.2/100 to 65.5/100.
Harper Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Harper Meds | NowPatient |
|---|---|---|
| WeighScore | 72.2/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #82 | #222 |
| Semaglutide | $149/mo | $1,349/mo (brand Wegovy) |
| Tirzepatide | $196/mo | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #82 · C
Strengths
- Flat pricing — same cost at every dose, no escalation as you titrate up
- All-inclusive: doctor consultation, prescription, medication, and free shipping in one price
- LegitScript-certified; prescriptions reviewed by US-licensed M.D.s
- Offers both compounded semaglutide ($149/mo) and tirzepatide ($196/mo)
Where it loses points
- Membership fee is non-refundable once paid
- Partner pharmacy is not publicly named
- State availability not published (limited to 'certain states')
Graded #222 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.